Antiviral and Antibacterial Therapy in the Treatment of Community-Acquired Pneumonia

O.A. Loskutov, O.M. Druzhyna, V.H. Kolesnikov

Abstract


This paper is intended to systematize the approaches to antiviral and antibacterial therapy in the treatment of community-acquired pneumonia. Currently, pneumonia is the leading cause of mortality among all infectious complications in all age groups and the sixth leading cause of death in the group of patients older than 65 years. The main component in the comprehensive treatment of patients with influenza pneumonia complicated by bacterial infection is the timely initiation of adequate antiviral and antibacterial therapy.
Antiviral therapy should be initiated at an early stage of the disease taking into account the clinical signs of the disease, without waiting for laboratory confirmation of influenza, because sensitivity to rapid tests can range from 10 to 70 %.
Antiviral therapy is based on the use of neuraminidase inhibitors, which are one of the main drugs for the treatment of viral pneumonia and influenza-like illnesses, both in adults and children. And early empiric antimicrobial therapy is useful for patients with symptoms of viral lung affection if they have concomitant purulent inflammatory processes.


Keywords


community-acquired pneumonia; antiviral and antibacterial therapy

References


Osler W. Has the mortality in pneumonia increased? / W. Osler // Med. Rec. (NewYork) — ​1888. — ​Vol. 34. — ​Р. 604.

Miniño A.M. Deaths: preliminary data for 2004 / A.M. Miniño, M.P. Heron, B.L. Smith // Natl. Vital. Stat. Rep. — 2006. — ​Vol. 54, № 19. — ​Р. 1-49.

Strausbaugh L.J. Emerging health care-associated infections in the geriatric population / L.J. Strausbaugh // Emerg. Infect. Dis. — 2001. — ​Vol. 7, № 2. — ​Р. 268-271.

Risk factors for community-acquired pneumonia in adults in Europe: a literature review / A. Torres, W.E. Peetermans, G. Viegi [et al.] // Thorax. — 2013. — ​Vol. 68, № 11. — ​Р. 1057-1065.

Wunderink R.G. Community-acquired pneumoni / R.G. Wunderink, G.W. Waterer // N. Engl. J. Med. — 2014. — ​Vol. 370, № 19. — ​Р. 1863.

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults / S. Jain, W.H. Self, R.G. Wunderink [et al.] // N. Engl. J. Med. — 2015. — ​Vol. 373, № 5. — ​P. 415-427.

Donowitz G.R. Community-acquired pneumonia: 2012 history, mythology, and science / G.R. Donowitz // Trans. Am. Clin. Climatol. Assoc. — 2013. — ​Vol. 124. — ​P. 283-293.

Viral etiology of community-acquired pneumonia among adolescents and adults with mild or moderate severity and its relation to age and severity / Jiu-Xin Qu, Li Gu, Zeng-Hui Pu [et al.] // BMC Infect. Dis. — 2015. — ​Vol. 15. — ​P. 89.

Pavia T.A. What is the Role of Respiratory Viruses in Community Acquired Pneumonia; What is the Best Therapy for Influenza and Other Viral Causes of CAP? / T.A. Pavia // Infect. Dis. Clin. North. Am. — 2013. — ​Vol. 27, № 1. — ​P. 157-175.

Rothberg M.B. Complications of seasonal and pandemic influenza / M.B. Rothberg, S.D. Haessler // Crit. Care Med. — 2010. — ​Vol. 38, № 3. — ​P. 1-7.

Cross-Reactive antibody responses to the 2009 pandemic H1N1 influenza virus / K. Hancock, V. Veguilla, X. Lu [et al.] // N. Engl. J. Med. — 2009. — ​Vol. 361, № 20. — ​P. 1945-1952.

Severe respiratory disease concurrent with the circulation of H1N1 Influenza / G. Chowell, S.M. Bertozzi, M.A. Colchero [et al.] // N. Engl. J. Med. — 2009. — ​Vol. 361. — ​P. 674-679.

Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) Virus Infection — ​United States, April-August 2009 / S. Shannon, J. Louie, E. Rico [et al.] // JAMA. — 2009. — ​Vol. 302, № 17. — ​P. 1855-1065.

US Centers for Disease Control and Prevention. Updated CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009 — ​April 10, 2010. [Eлeктрoнний рecурc] — ​2010. — ​Рeжим дocтупу: http:// www.cdov/h1n1flu/estimates_2009 h1n1.htm (Accessed June 7, 2010). — ​Нaзвa з титул. eкрaну.

Міністерство охорони здоров’я України. Інформація щодо захворюваності на грип та гострі респіраторні захворювання та їх ускладнення (пневмонії тощо) за період з 22 по 28 березня (12-й тиждень) 2010 р. [Eлeктрoнний рecурc] — ​2010. — ​Рeжим дocтупу: http: // www.moz.gov.ua/ua/main/press/?docID = 15184. — ​Нaзвa з титул. eкрaну.

Novel Swine-Origin Influenza A(H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans / F.S. Dawood, S. Jain, L. Finelli [et al.] // N. Engl. J. Med. — 2009. — ​Vol. 360, № 25. — ​P. 2605-2615.

Critically ill patients with novel swine origin influenza virus A/H1N1 infection in Canada / A. Kumar, R. Zarychanski, R. Pinto [et al.] // JAMA. — 2009. — ​Vol. 302, № 17. — ​P. 1872-1879.

Mishra A.C. Pandemic influenza (H1N1) 2009 is associated with severe disease in India / A.C. Mishra, M.S. Chadha, M.L. Choudhary [et al.] // PLos. One. — 2010. — ​Vol. 5, № 5. — ​e10540.

Pulmonary pathologic findings of fatal 2009 pandemic influenza A(H1N1) viral infections / J.R. Gill, Z.M. Sheng, S.F. Ely [et al.] // Arch. Pathol. Lab. Med. — 2010. — ​Vol. 134, № 2. — ​P. 235-243.

Патоморфология легких при тяжелом гриппе А/H1N1 / О.В. Зайратьянц, А.А. Черняев, А.Г. Чухалин [и др.] // Анестезиология и реаниматология. — 2010. — № 3. — ​P. 25-29.

Guarner J. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses / J. Guarner, R. Falcón-Esco­bedo // Arch. Med. Res. — 2009. — ​Vol. 40, № 8. — ​P. 655-661.

Sudden death of a patient with pandemic influenza A(H1N1) virus infection by acute respiratory distress syndrome / A. Takiyama, L. Wang, M. Tanino [et al.] // Jpn. J. Infect. Dis. — 2010. — ​Vol. 63, № 1. — ​P. 72-74.

Bidiga L. New influenza virus (H1N1) related pneumonia with fatal outcome / L. Bidiga, L. Asztalos, Z. Fülep [et al.] // Orv. Hetil. — 2010. — ​Vol. 151, № 14. — ​P. 576-579.

Standing J.F. Oseltamivir Pharmacokinetics and Clinical Experience in Neonates and Infants during an Outbreak of H1N1 Influenza A Virus Infection in a Neonatal Intensive Care Unit / J.F. Standing, A. Nika, V. Tsagris // Antimicrob. Agents Chemo­ther. — 2012. — ​Vol. 56, № 7. — ​P. 3833-3840.

Michiels B. The Value of Neuraminidase Inhibitors for the Prevention and Treatment of Seasonal Influenza: A Systematic Review of Systematic Reviews / B. Michiels, K. Van Puyenbroeck, V. Verhoeven // PLoS. One. — 2013. — ​Vol. 8, № 4. — ​e60348.

Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics / N. Widmer, P. Meylan, A. Ivanyuk [et al.] // Clin. Pharmacokinet. — 2010. — ​Vol. 49, № 11. — ​P. 741-765.

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children / T. Jefferson, M.A. Jones, P. Doshi [et al.] // Cochrane Database Syst. Rev. — 2014. — ​Vol. 4. — ​CD008965.

Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) United States, may-august 2009 / J. Louie, C. Jean, T.-H. Chen [et al.] // JAMA. — 2009. — ​Vol. 302. — ​P. 1852-1854.

Lung pathology in fatal novel human influenza A (H1N1) infection / T. Mauad, L.A. Hajjar, G.D. Callegari [et al.] // Am. J. Respir. Crit. Care Med. — 2010. — ​Vol. 181. — ​P. 72-79.

Pandemic (H1N1) 2009 influenza / M. Patel, A. Dennis, C. Flutter, Z. Khan // British Journal of Anaesthesia. — 2010. — ​Vol. 104, № 2. — ​P. 128-142.

Wedzicha J.A. Pandemic flu: clinical management of patients with an influenzalike illness during an influenza pandemic. Provisional guidelines from the British Infection Society, Bri­tish Thoracic Society, and Health Protection Agency in collaboration with the Department of Health / J.A. Wedzicha // Thorax. — 2007. — ​Vol. 62 (suppl. 1). — ​P. 1-58.

Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit / A. Rodríguez, L. Alvarez-Rocha, J.M. Sirvent [et al.] // Med. Intensiva. — 2012. — ​Vol. 36, № 2. — ​Р. 103-137.

Mandell L.A. Community-acquired pneumonia / L.A. Mandell, R.G. Wunderink, G.W. Waterer // N. Engl. J. Med. — 2015. — ​Vol. 372, № 3. — ​P. 293-294.

Moran G.J. Emergency management of community-acquired bacterial pneumonia: what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines / G.J. Moran, R.E. Rothman, G.A. Volturo // Am. J. Emerg. Med. — 2013. — ​Vol. 31, № 3. — ​P. 602-612.

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock / A. Kumar, D Roberts, K.E. Wood [et al.] // Crit. Care Med. — 2006. — ​Vol. 34, № 6. — ​P. 1589-1596.

Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults / L.A. Mandell, R.G. Wunderink, A. Anzueto [et al.] // Clin. Infect. Dis. — 2007. — ​Vol. 44 ­(Suppl. 2). — ​P. 27-72.




DOI: https://doi.org/10.22141/2224-0586.3.74.2016.76139

Copyright (c) 2016 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта